Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Introduction to a review series: the paradox of indolent B-cell lymphoma.

× No keyword cloud information.

5 in total

1. B-cell lymphomas with discordance between pathological features and clinical behavior.

Authors: Laurence de Leval; Christiane Copie-Bergman; Andreas Rosenwald; Lisa Rimsza; Stefania Pittaluga; Bettina Bisig; Stefan Dirnhofer; Fabio Facchetti; Stefano Pileri; Falko Fend; Andrew Wotherspoon
Journal: Virchows Arch Date: 2017-06-01 Impact factor: 4.064

Review 2. Targeting B cell receptor signalling in cancer: preclinical and clinical advances.

Authors: Jan A Burger; Adrian Wiestner
Journal: Nat Rev Cancer Date: 2018-01-19 Impact factor: 60.716

Review 3. Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs.

Authors: Davide Facchinelli; Gessica Marchesini; Gianpaolo Nadali; Livio Pagano
Journal: Mediterr J Hematol Infect Dis Date: 2018-11-01 Impact factor: 2.576

4. Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's Lymphoma and Role of β2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China.

Authors: Yujie Zhang; Donghua He; Jingsong He; Weijia Huang; Yang Yang; Zhen Cai; Yi Zhao
Journal: Comput Math Methods Med Date: 2022-01-20 Impact factor: 2.238

5. Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study.

Authors: Ian W Flinn; Manish Patel; Yasuhiro Oki; Steven Horwitz; Francine F Foss; Kerstin Allen; Mark Douglas; Howard Stern; Jennifer Sweeney; Jahnavi Kharidia; Patrick Kelly; Virginia M Kelly; Brad Kahl
Journal: Am J Hematol Date: 2018-08-31 Impact factor: 10.047

5 in total